The development of a new injectable drug requires several steps, ranging from pre-clinical research to clinical trials in different phases, and finally reaching full commercialization.

The increasing requirements from regulatory authorities (such as Annex I) and the emergence of new products compared to traditional synthetic drugs (for example, ADCs, ATMPs, Cell & Gene therapies) have demanded technological adaptation in Fill-Finish systems to be implemented throughout all stages of drug development.

The ability to increase the level of automation within an appropriate containment system (RABS or Isolator) , both during commercialization but also in earlier phases, ensures better quality for the final product.

Attending this webinar you could see Comecer's solutions as:

• Table-top modules for R&D and clinical trials
• Flexible solutions for small batch productions
• Commercial-scale production lines

Join us on the Road to INTERPHEX for three live webinars dedicated to our expanded offering of a new generation of solutions designed for today's most demanding injectable and non-injectable applications.

Registration is now closed.
The webinar will soon be available on demand.